Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Van Cott

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Seminars in Thrombosis and Hemostasis|September 3, 2020
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)Bianca Christensen, Emmanuel J Favaloro, Giuseppe Lippi, et al.
Biochemical and Biophysical Research Communications|March 19, 2021
Complement component factor B has thrombin-like activityKazue Takahashi, Nirmal K Banda, V Michael Holers, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testingZachary Liederman, Elizabeth M Van Cott, Kristi Smock, et al.
American Journal of Hematology|January 29, 2014
Heparin, warfarin, or calciphylaxis?Rory Crotty, Rosalynn M Nazarian, Philip I Song, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Patent foramen ovale and hypercoagulability as combined risk factors for strokeJose C Florez, Hakan Ay, Elizabeth M Van Cott, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 23, 2013
Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopeniaPaul A Arpino, Adrienne J Goeller, Anthony Fatalo, et al.
Journal of the American Academy of Dermatology|July 21, 2009
Warfarin-induced skin necrosisRosalynn M Nazarian, Elizabeth M Van Cott, Artur Zembowicz, et al.
Thrombosis and Haemostasis|March 12, 2009
Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisationStanley Chia, Elizabeth M Van Cott, O Christopher Raffel, et al.
Biomedical Optics Express|April 2, 2014
Assessing blood coagulation status with laser speckle rheologyMarkandey M Tripathi, Zeinab Hajjarian, Elizabeth M Van Cott, et al.
International Journal of Laboratory Hematology|February 9, 2019
Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand diseaseAchuta K Guddati, Rachel P Rosovsky, Elizabeth M Van Cott, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Seminars in Thrombosis and Hemostasis|September 3, 2020
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)Bianca Christensen, Emmanuel J Favaloro, Giuseppe Lippi, et al.
Biochemical and Biophysical Research Communications|March 19, 2021
Complement component factor B has thrombin-like activityKazue Takahashi, Nirmal K Banda, V Michael Holers, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testingZachary Liederman, Elizabeth M Van Cott, Kristi Smock, et al.
American Journal of Hematology|January 29, 2014
Heparin, warfarin, or calciphylaxis?Rory Crotty, Rosalynn M Nazarian, Philip I Song, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Patent foramen ovale and hypercoagulability as combined risk factors for strokeJose C Florez, Hakan Ay, Elizabeth M Van Cott, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 23, 2013
Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopeniaPaul A Arpino, Adrienne J Goeller, Anthony Fatalo, et al.
Journal of the American Academy of Dermatology|July 21, 2009
Warfarin-induced skin necrosisRosalynn M Nazarian, Elizabeth M Van Cott, Artur Zembowicz, et al.
Thrombosis and Haemostasis|March 12, 2009
Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisationStanley Chia, Elizabeth M Van Cott, O Christopher Raffel, et al.
Biomedical Optics Express|April 2, 2014
Assessing blood coagulation status with laser speckle rheologyMarkandey M Tripathi, Zeinab Hajjarian, Elizabeth M Van Cott, et al.
International Journal of Laboratory Hematology|February 9, 2019
Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand diseaseAchuta K Guddati, Rachel P Rosovsky, Elizabeth M Van Cott, et al.
Pageof 11